The App is based on the AAD psoriasis clinical guidelines. Adherence to the guidelines recommendations will not ensure successful treatment in every situation. Furthermore, these guidelines should not be interpreted as setting a standard of care, or be deemed inclusive of all proper methods of care nor exclusive of other methods of care reasonably directed to obtaining the same results. The ultimate judgment regarding the propriety of any specific therapy must be made by the physician and the patient in light of all the circumstances presented by the individual patient, and the known variability and biological behavior of the disease. This guideline reflects the best available data at the time the guideline was prepared. The results of future studies may require revisions to the recommendations in this guideline to reflect new data.
Administration advice :
-Self-administration should be limited to patients who are motivated, adequately trained, and have access to advice.
-Prior to administration, patients should be instructed on proper administration techniques, including the principles of sterile techniques.
-Once administered, needles and syringes should be placed in a sealable, puncture-resistant container.
Storage requirements :
-HCG: Once reconstituted, use completely; some reconstituted formulations may be stable for a few days when refrigerated. The manufacturer product information should be consulted for further details.
-r-HCG: Protect from light; store in the refrigerator until just prior to use.
Reconstitution/preparation techniques :
-The manufacturer product information should be consulted.
-Use may aid in predicting whether orchiopexy will be needed in patients with prepubertal cryptorchidism.
-Limitation of use: Use for ovulation and pregnancy should be limited to patients who are receiving a follicle stimulating agents or human menopausal gonadotropins (menotropins).
-Limitation of use: r-HCG has not been studied in male patients and for use in patients with corpus luteum insufficiency.
-Cardiovascular: Signs/symptoms of thrombotic events
-Endocrine: Estradiol levels
-Genitourinary: Ovarian response to treatment (via transvaginal ultrasound)
-Musculoskeletal: Skeletal maturation in patients treated for delayed puberty
Patient advice :
-Patients should be told to report signs/symptoms of ovarian hyperstimulation syndrome, thrombotic events, and ovarian torsion.
-Patients should be told that use of this drug requires monitoring of ovarian response with/without estradiol levels.
-Patients should be instructed to properly dispose of used needles and syringes.
-Advise patients to speak to their healthcare provider if they become pregnant, intend to become pregnant, or are breastfeeding.
Our doctors understand your body from a scientific standpoint, as well as the internal and external factors associated with weight loss. External factors, which include the foods we eat and how we exercise, are important and are the typical focus of most all weight loss programs. However, the internal factors, which include an understanding of why your body is unable to lose weight, are often not addressed, yet they are the most important factors. Internal factors can include hormonal imbalances, medications, and diseases such as diabetes, This is why you will succeed with us; the doctors at Revita have a greater knowledge and understanding of how to get your body to what we call “medically optimal.” Without understanding how to achieve medically optimal, you will stay on the weight loss roller coaster. This is why every Revita patient must spend time with the doctor for a full diagnosis of why they gained weight, how to lose the weight, and most importantly, how manage long-term weight loss.